HuMAB companies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HuMAB companies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (112)	2/6/2001 10:27:06 AM
From: nigel bates	of 1022

Feb. 6 /PRNewswire/ -- Medarex, Inc. (Nasdaq: MEDX - news) announced today that its licensee, Centocor, Inc., a wholly owned subsidiary of Johnson & Johnson, filed an IND (Investigational New Drug application) with the FDA for the investigation of a fully human antibody product in the treatment of inflammatory disease. The fully human antibody product was developed using Medarex's HuMAb-Mouse® technology. ``This is the third fully human antibody product developed with our HuMAb- Mouse system to enter human clinical trials,'' said Donald L. Drakeman, President and CEO of Medarex. ``We are pleased to be continuing our collaboration with Centocor to develop fully human antibody therapeutics.''....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next